Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00170872
Status:
COMPLETED
Last Update Posted:
2012-05-21
First Post:
2005-09-09
Brief Title:
6 Week Open-label Trial With Lumiracoxib 200mg od in Primary Knee Osteoarthritis or Rheumatoid Arthritis
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A 6 Week Multicenter Open-label Trial to Evaluate the Safety Tolerability and Efficacy of Lumiracoxib 200mg od in Patients With Primary Knee Osteoarthritis or Rheumatoid Arthritis
Status:
COMPLETED
Status Verified Date:
2012-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study tested the safety tolerability and efficacy of lumiracoxib - a COX-2 inhibitor- in patients with primary knee osteoarthritis or rheumatoid arthritis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None